ANDA > Nova Content
Written by: Makoto Tsunozaki, Ph.D. & Agnes Juang, Ph.D.
On October 22, 2024, Novo Nordisk made a submission to the U.S. Food and... Read More »
Written by: Joseph Reisman, Ph.D. & Sophia Zahn
As the FTC continues to crack down on pharmaceutical... Read More »
The competitive landscape of ANDA litigation has played a significant role in shaping the pharmaceutical industry, showcasing the legal experts who ... Read More »
In the pharmaceutical industry, innovation drives progress, but intense legal battles, particularly in ANDA (Abbreviated New Drug... Read More »
Written by: Rhett D. Ramsey & Joseph Mallon, Ph.D.
Judge Andrews of the District of Delaware recently denied Novartis’s... Read More »
As the pharmaceutical industry continues to face an ever-changing legal environment, staying informed about trends in ANDA litigation has... Read More »
Written by: Sophia Zahn & Jason J. Jardine
The June 2024 issue of Vanity Fair included the provocative headline: “Why... Read More »
Revlimid (lenalidomide), developed by Celgene Corporation, has been a groundbreaking treatment for multiple myeloma, myelodysplastic... Read More »
Comments
Vincent AndolinaVolume-limited "authorized generic" lenalidomide capsules are available from multiple generic distribitors as noted in the REMS list (see link below):https://www.lenalidomiderems.com/products-covered/index.html
Jul 26, 2024
Written by: Nicole E. Kim & Douglas B. Wentzel
AMARIN PHARMA, INC. v. HIKMA PHARMACEUTICALS USA INC.
Before Moore, Lourie, ... Read More »
Moderna recently registered a significant triumph in its ongoing patent dispute concerning its Covid-19 vaccine against Pfizer and... Read More »
Written by: Rhett D. Ramsey & Daniel Kiang
JANSSEN PHARMACEUTICALS, INC. v. TEVA PHARMACEUTICALS USA, INC... Read More »
Written by: Zachary B. Messick & Jacob R. Rosenbaum
SALIX PHARMACEUTICALS, LTD. v. NORWICH PHARMACEUTICALS., INC.
Before... Read More »
Written by: Brianne M. Kingery & Jason J. Jardine
The Biden Administration’s Inflation Reduction Act (IRA)’s... Read More »
Written by: Raymond S. Lu & Brandon G. Smith
PFIZER INC. v. SANOFI PASTEUR INC.
Before Lourie, Bryson, and Stark. ... Read More »
As the relentless march of time continues, pharmaceutical executives find themselves facing the inevitability of patent expirations and... Read More »
BeiGene, a biotechnology company, has taken legal action by filing patent infringement lawsuits against pharmaceutical companies Sandoz... Read More »
Shares of UroGen Pharma (NASDAQ: URGN) took a minor premarket hit following news that Teva Pharmaceutical (NYSE: TEVA) has submitted an... Read More »
Corcept Therapeutics experienced a significant drop in its stock value by 27% on Tuesday following an unfavorable verdict... Read More »
Source: https://www.greyb.com/blog/drug-patents-expiring-2024/
The pharmaceutical industry is undergoing a... Read More »
In late August of this year, our ANDA Intelligence 2023 Report was released, a comprehensive study, covering the Hatch-Waxman litigation within US... Read More »